We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+8.15%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+367.78%
AUM
$287B
AUM Growth
+$27.6B
Cap. Flow
+$6.59B
Cap. Flow %
2.29%
Top 10 Hldgs %
12.98%
Holding
8,864
New
808
Increased
4,306
Reduced
2,684
Closed
688

Sector Composition

Rank Sector Weight
1 Technology 9.82%
2 Financials 7.38%
3 Healthcare 6.65%
4 Consumer Discretionary 5.46%
5 Industrials 5.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FDMO icon
6176
Fidelity Momentum Factor ETF
FDMO
$958M
$70K ﹤0.01%
1,904
+345
+22% +$12.2K
IVLU icon
6177
iShares MSCI Intl Value Factor ETF
IVLU
$4.55B
$70K ﹤0.01%
2,891
+267
+10% +$6.36K
MKC.V icon
6178
McCormick & Company Voting
MKC.V
$14.2B
$70K ﹤0.01%
822
-1,118
-58% -$92.4K
UGE icon
6179
ProShares Ultra Consumer Staples
UGE
$12M
$70K ﹤0.01%
5,272
ICD
6180
DELISTED
Independence Contract Drilling, Inc.
ICD
$70K ﹤0.01%
3,514
+1,594
+83% +$28.4K
KLDO
6181
DELISTED
Kaleido Biosciences, Inc. Common Stock
KLDO
$70K ﹤0.01%
14,026
+10,172
+264% +$64.6K
JOF
6182
Japan Smaller Capitalization Fund
JOF
$350M
$69K ﹤0.01%
7,688
-3,119
-29% -$28.3K
SLVP icon
6183
iShares MSCI Global Silver and Metals Miners ETF
SLVP
$944M
$69K ﹤0.01%
6,155
EVLO
6184
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
$69K ﹤0.01%
854
+201
+31% +$22.5K
HEWL
6185
DELISTED
iShares Currency Hedged MSCI Switzerland ETF
HEWL
$69K ﹤0.01%
2,212
-458
-17% -$13.9K
CPRX
6186
DELISTED
Catalyst Pharmaceutical
CPRX
$68K ﹤0.01%
18,175
-208,305
-92% -$974K
ES icon
6187
PUT
Eversource Energy
ES
$27.2B
$68K ﹤0.01%
800
GHYB icon
6188
Goldman Sachs Access High Yield Corporate Bond ETF
GHYB
$134M
$68K ﹤0.01%
1,365
+638
+88% +$31.4K
ISSC icon
6189
Innovative Solutions & Support
ISSC
$361M
$68K ﹤0.01%
11,600
-1,368
-11% -$6.61K
SND icon
6190
Smart Sand
SND
$194M
$68K ﹤0.01%
26,786
+10,168
+61% +$25.1K
SONM icon
6191
DNA X Inc
SONM
$5.63M
$68K ﹤0.01%
10
+8
+400% +$39.5K
TVTY
6192
DELISTED
Tivity Health, Inc. Common Stock
TVTY
$68K ﹤0.01%
3,347
-38,371
-92% -$718K
BAK icon
6193
Braskem
BAK
$913M
$67K ﹤0.01%
+4,499
New +$62.9K
DIT icon
6194
AMCON Distributing
DIT
$67K ﹤0.01%
1,404
+430
+44% +$20.8K
LEGR icon
6195
First Trust Indxx Innovative Transaction & Process ETF
LEGR
$133M
$67K ﹤0.01%
2,109
+175
+9% +$5.34K
MSVB
6196
DELISTED
Mid-Southern Bancorp, Inc.
MSVB
$67K ﹤0.01%
5,000
JPLS
6197
DELISTED
JPMorgan Long/Short ETF
JPLS
$67K ﹤0.01%
3,055
+2,055
+206% +$45.1K
GSP
6198
DELISTED
Barclays Bank PLC iPath Exchange Traded Notes due 2036 Linked to GSCI Total Return Index
GSP
$67K ﹤0.01%
4,291
-3,148
-42% -$46.3K
SYE
6199
DELISTED
SPDR MFS Systematic Core Equity ETF of SSgA Active Trust
SYE
$67K ﹤0.01%
+750
New +$64.5K
NIHD
6200
DELISTED
NII Holdings, Inc. Common Stock
NIHD
$67K ﹤0.01%
30,747
-1,753,750
-98% -$3.39M

Similar funds

UBS Group's Q4 2019 Portfolio in Review

As of Q4 2019, UBS Group held 8,864 positions worth $287B, up 11% from $260B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

UBS Group's Q4 2019 filing shows 808 new, 4,306 increased, 2,684 reduced and 688 closed positions. Its largest new stake was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.3B.

By sector, the portfolio is most concentrated in Technology at 9.8% of assets, up from 9.5% a quarter earlier, followed by Financials and Healthcare.

  • UBS Group's largest Q4 2019 buy was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M.
  • UBS Group added most to UBS Group in Q4 2019, an estimated $1.48B increase.
  • UBS Group's biggest Q4 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.3B.
  • UBS Group fully exited Altaba Inc in Q4 2019, selling an estimated $759M.
  • UBS Group's ten largest holdings make up 13% of its $287B portfolio in Q4 2019.
  • UBS Group opened 808 new positions and closed 688 in Q4 2019.
  • UBS Group's portfolio value rose 11% quarter-over-quarter to $287B.

Based on UBS Group's 13F filing for Q4 2019, filed 14 Feb 2020.